Literature DB >> 8264139

Evidence for high risk of cerebral hemorrhage in chronic dialysis patients.

K Iseki1, K Kinjo, Y Kimura, A Osawa, K Fukiyama.   

Abstract

One-half of the total deaths in chronic dialysis patients are due to cardiovascular disease; however, the precise incidence and relative risk of those compared to normals are not known. Therefore, we sought to determine the annual incidence of cardiovascular disease and relative risk of those on chronic dialysis to the general population. Both the general population (1.2 million, Census 1990) and chronic dialysis patients (N = 1,609) in Okinawa, Japan were studied prospectively from April, 1988, to March, 1991. Diagnosis of stroke was made by symptoms and brain CT scan, and acute myocardial infarction was done by changes in electrocardiogram and serum enzymes. The relative risk (observed/expected ratio) was calculated by using the standardized morbidity rate obtained in both sexes and age-class every 10 years in the general population. Forty-one stroke (8 cerebral infarction, 31 cerebral hemorrhage, and 2 subarachnoid hemorrhage) and four acute myocardial infarction cases were registered during the study period in chronic dialysis patients. The incidence per 1,000 person-year was 11.5 in stroke, 2.2 in cerebral infarction, 8.7 in cerebral hemorrhage, 0.6 in subarachnoid hemorrhage, and 1.1 in acute myocardial infarction. The relative risk compared to normals was 5.2 in stroke, 2.0 in cerebral infarction, 10.7 in cerebral hemorrhage, 4.0 in subarachnoid hemorrhage, and 2.1 in acute myocardial infarction. Cerebral hemorrhage occurred at 10 years younger than that of the general population (P < 0.001) and was associated with high prevalence of hypertension and low levels of serum albumin and cholesterol. Our results confirm the importance of blood pressure control and nutritional status in chronic dialysis patients.

Entities:  

Mesh:

Year:  1993        PMID: 8264139     DOI: 10.1038/ki.1993.352

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  37 in total

1.  Rosuvastatin in diabetic hemodialysis patients.

Authors:  Hallvard Holdaas; Ingar Holme; Roland E Schmieder; Alan G Jardine; Faiez Zannad; Gudrun E Norby; Bengt C Fellström
Journal:  J Am Soc Nephrol       Date:  2011-05-12       Impact factor: 10.121

2.  Ischemic stroke: the impact of renal dysfunction on 1-year mortality.

Authors:  Tanja Hojs Fabjan; Radovan Hojs
Journal:  Wien Klin Wochenschr       Date:  2015-03-19       Impact factor: 1.704

3.  Warfarin Use and Increased Mortality in End-Stage Renal Disease.

Authors:  Mark C Lin; Elani Streja; Melissa Soohoo; Medhat Hanna; Javad Savoj; Kamyar Kalantar-Zadeh; Wei Ling Lau
Journal:  Am J Nephrol       Date:  2017-09-15       Impact factor: 3.754

Review 4.  Oral Anticoagulation in Patients With End-Stage Kidney Disease on Dialysis and Atrial Fibrillation.

Authors:  Austin Hu; Jingbo Niu; Wolfgang C Winkelmayer
Journal:  Semin Nephrol       Date:  2018-11       Impact factor: 5.299

Review 5.  Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction.

Authors:  Tatjana S Potpara; Charles J Ferro; Gregory Y H Lip
Journal:  Nat Rev Nephrol       Date:  2018-03-26       Impact factor: 28.314

6.  Predicting symptomatic intracerebral hemorrhage versus lacunar disease in patients with longstanding hypertension.

Authors:  Elisabeth B Marsh; Rebecca F Gottesman; Argye E Hillis; Joyce Maygers; Erin Lawrence; Rafael H Llinas
Journal:  Stroke       Date:  2014-05-08       Impact factor: 7.914

7.  Impact of atrial fibrillation on the risk of ischemic stroke in patients on hemodialysis: BOREAS-HD3 Study.

Authors:  Ayumu Kimura; Marenao Tanaka; Norihito Moniwa; Arata Osanami; Koki Abe; Daisuke Miyamori; Yufu Gocho; Satoru Shibata; Makoto Terasawa; Yusuke Okazaki; Tomohisa Yamashita; Masayuki Koyama; Masato Furuhashi; Hirofumi Ohnishi; Tetsuji Miura
Journal:  Clin Exp Nephrol       Date:  2020-11-18       Impact factor: 2.801

8.  Stroke in chronic kidney disease.

Authors:  P Rama Krishna; S Naresh; G S R Krishna; A Y Lakshmi; B Vengamma; V Siva Kumar
Journal:  Indian J Nephrol       Date:  2009-01

Review 9.  Antiplatelet medications in hemodialysis patients: a systematic review of bleeding rates.

Authors:  Swapnil Hiremath; Rachel M Holden; Dean Fergusson; Deborah L Zimmerman
Journal:  Clin J Am Soc Nephrol       Date:  2009-07-02       Impact factor: 8.237

10.  A case of Dunnigan-type familial partial lipodystrophy (FPLD) due to lamin A/C (LMNA) mutations complicated by end-stage renal disease.

Authors:  Hitomi Imachi; Koji Murao; Shouji Ohtsuka; Mako Fujiwara; Tomie Muraoka; Hitoshi Hosokawa; Toshihiko Ishida
Journal:  Endocrine       Date:  2008-11-15       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.